Virus Dataset Detail

> Detail information for each sample

Dataset Information
Accession GSE211934
Status 2023/8/24
Title Pathological effects of SARS-CoV-2 and α-synuclein preformed fibril in hESC-derived dopaminergic neurons
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Summary Progression Parkinson’s disease (PD) has been strongly correlated to concurrent virus infection such as herpes virus, Helicobacter pylori, hepatitis C, and pneumococcus and the concurrent immune response in the brain. However, the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the onset and progression of PD is yet to be investigated. As the pandemic is getting closer to being under control and majority of the population in the world will have been infected with SARS-CoV-2, there will be a huge need for uncovering the unknown, possible neurological sequelae of SARS-CoV-2 infection. Here we report that SARS-CoV-2 infection increased the susceptibility of DA neurons to PFF-induced cell death while PFF or SARS-CoV-2 alone did not exert a cytotoxic effect on dopaminergic (DA) neurons. RNA sequencing data revealed mechanistic investigations that SARS-CoV-2, in vitro, increased susceptibility to PFF-induced PD-like pathology including changes in expression of signaling molecules in apoptosis, autophagy, oxidative stress, and mitochondrial function. Thus, our study provides a previously unappreciated paradigm that SARS-CoV-2 infection persists in the brain and increases susceptibility to neurodegenerative diseases such as PD via continuous inflammatory response as a long-term sequela.
Samples
GSM ID Sample info Characteristics Description
GSM6505758 DAneuron, non-treated, rep1 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation -
GSM6505759 DAneuron, non-treated, rep2 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation -
GSM6505760 DAneuron, SARS-CoV-2, rep1 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, SARS-CoV-2 infection -
GSM6505761 DAneuron, SARS-CoV-2, rep2 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, SARS-CoV-2 infection -
GSM6505762 DAneuron, PFF, rep1 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, a-synuclein preformed fibril -
GSM6505763 DAneuron, PFF, rep2 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, a-synuclein preformed fibril -
GSM6505764 DAneuron, PFF and SARS-CoV-2, rep1 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, a-synuclein preformed fibril, SARS-CoV-2 infection -
GSM6505765 DAneuron, PFF and SARS-CoV-2, rep2 cell line:WA09 hESC; cell type:hESC-derived dopaminergic neuron; genotype:WT; treatment:Dopaminergic neuron differentiation, a-synuclein preformed fibril, SARS-CoV-2 infection -
Platform GPL24676  : Illumina NovaSeq 6000 (Homo sapiens)
Literature 38749422  
Download Download xCell Data  Download Expression Analysis Data  
xCell Plot
* p<0.05 ** p<0.01